waldenstrom macroglobulinemia
Showing 51 - 75 of 154
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +71 more
- lenalidomide
- +8 more
-
Chicago, Illinois
- +5 more
Oct 8, 2021
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
-
Chicago, Illinois
- +2 more
Aug 30, 2021
Waldenstrom Macroglobulinemia Trial in New York (Epratuzumab (hLL2- anti-CD22 humanized antibody))
Terminated
- Waldenstrom Macroglobulinemia
- Epratuzumab (hLL2- anti-CD22 humanized antibody)
-
New York, New York
- +1 more
Aug 12, 2021
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +22 more
- Ibrutinib
- +3 more
-
Scottsdale, Arizona
- +1 more
Aug 10, 2021
Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)
Completed
- Waldenström Macroglobulinemia
- Blood or bone marrow samples
-
Vandoeuvre les Nancy, FranceCHRU Nancy
Aug 1, 2021
Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee
Enrolling by invitation
- Monoclonal Gammopathy of Undetermined Significance
- +6 more
-
Milwaukee, WisconsinAurora Health Care
Jul 20, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose
Completed
- B-cell Lymphoma
- +2 more
- BI-1206 single agent dose escalation phase
- +3 more
-
Leicester, England, United Kingdom
- +4 more
Jun 17, 2021
Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia Trial in Amiens (other, biological, procedure)
Recruiting
- Hyperviscosity Syndrome
- Waldenstrom Macroglobulinemia
- fundoscopic picture
- +2 more
-
Amiens, FranceCHU Amiens
May 19, 2021
Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)
Recruiting
- Waldenstrom's Disease
- Waldenstrom Macroglobulinemia
- bone marrow sample
- blood sample
-
Amiens, FranceCHU Amiens
May 17, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021
Waldenstrom Macroglobulinemia Trial in United Kingdom (Pembrolizumab, Rituximab)
Recruiting
- Waldenstrom Macroglobulinemia
-
Plymouth, Devon, United Kingdom
- +7 more
May 17, 2021
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Not yet recruiting
- Multiple Myeloma
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2021
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)
Terminated
- Lymphoma, T-Cell, Cutaneous
- +6 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 20, 2021
Genomic, Transcriptomic and Functional Characteristics of Tumor
Not yet recruiting
- Monoclonal Gammopathy of Undetermined Significance
- +2 more
-
Paris, FranceService de Médecine Interne
Jan 8, 2021
Waldenstrom Macroglobulinemia Trial in United Kingdom (Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib)
Recruiting
- Waldenstrom Macroglobulinemia
- Dexamethasone, cyclophosphamide, rituximab
- Rituximab, ibrutinib
-
Bournemouth, United Kingdom
- +6 more
Dec 16, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
-
Scottsdale, Arizona
- +1 more
Sep 28, 2020
Waldenström Macroglobulinemia Trial in Tianjin (Zanubrutinib,Ixazomib and Dexamethasone)
Recruiting
- Waldenström Macroglobulinemia
- Zanubrutinib,Ixazomib and Dexamethasone
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 8, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020